Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2020 ,inter alia, to consider and approve We would like to inform you that the meeting of the Board of Directors will be held on Monday, 26-Oct-20, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-20.
13-10-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for half year ended on 30th September, 2020.
09-10-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer
09-10-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window

Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st October, 2020 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter ended 30th September, 2020 to the Stock Exchanges.
30-09-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
27-09-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Pursuant to Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, we would like to inform you that the Company has amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (as enclosed) pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2020.
19-09-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating

With reference to our earlier letter dated 26-Aug-20 on the captioned subject, we would like to inform you that there was the typo error in the credit rating of Commercial Papers. The corrected details are as per the attached letter
27-08-2020
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, it is hereby informed that ICRA Limited has re-affirmed the credit rating as per the attached letter.
26-08-2020
Next Page
Close

Let's Open Free Demat Account